Down-regulated GFAPα: A major player in heavy metal induced astrocyte damage

Toxicology Mechanisms and Methods

Volumn 23, Issue 2, 2013, Pages 99-107

  Rai, Asit ^a,b,c   Maurya, Shailendra Kumar ^b   Sharma, Rolee ^c   Ali, Shakir ^a  

^a HAMDARD UNIVERSITY   (India)

^b CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^c INTEGRAL UNIVERSITY   (India)

Author keywords

Astrocyte apoptosis; GFAP isoform; Morphological aberrations

Indexed keywords

ARSENIC; CADMIUM; DRINKING WATER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN ALPHA; HEAVY METAL; LEAD; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CORTEX; CELL DAMAGE; CELL SHAPE; CELL VIABILITY; DOWN REGULATION; GENE SILENCING; NEUROTOXICOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; ARSENITES; ASTROCYTES; BRAIN; CADMIUM CHLORIDE; DOWN-REGULATION; DRUG COMBINATIONS; FEMALE; GENE SILENCING; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MATERNAL EXPOSURE; ORGANOMETALLIC COMPOUNDS; PREGNANCY; PROTEIN ISOFORMS; RATS; RNA, SMALL INTERFERING; SODIUM COMPOUNDS; TRANSFECTION;

EID: 84873807657     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.721809     Document Type: Article

References (44)

1. Andreiuolo F, Junier MP, Hol EM, Miquel C, Chimelli L, Leonard N, Chneiweiss H, Daumas-Duport C, Varlet P. 2009. GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneity. Neuropathology 29: 31-39.
2. Blechingberg J, Holm IE, Nielsen KB, Jensen TH, Jgensen AL, Nielsen AL. 2007. Identification and characterization of GFAPkappa, a novel glial fibrillary acidic protein isoform. Glia 55: 497-507.
3. Boer K, Middeldorp J, Spliet WG, Razavi F, van Rijen PC, Baayen JC, Hol EM, Aronica E. 2010. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy. Epilepsy Res 90: 99-109.
4. Boyd SE, Nair B, Ng SW, Keith JM, Orian JM. 2012. Computational characterization of 3' splice variants in the GFAP isoform family. PLoS ONE 7: e33565.
5. Brender JD, Suarez L, Felkner M, Gilani Z, Stinchcomb D, Moody K, Henry J, Hendricks K. 2006. Maternal exposure to arsenic, cadmium, lead, and mercury and neural tube defects in offspring. Environ Res 101: 132-139.
6. Catanzaro I, Schiera G, Sciandrello G, Barbata G, Caradonna F, Proia P, Di Liegro I. 2010. Biological effects of inorganic arsenic on primary cultures of rat astrocytes. Int J Mol Med 26: 457-462.
7. Choi KC, Kwak SE, Kim JE, Sheen SH, Kang TC. 2009. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor. Neurosci Lett 463: 182-187.
8. Condorelli DF, Nicoletti VG, Barresi V, Conticello SG, Caruso A, Tendi EA, Giuffrida Stella AM. 1999. Structural features of the rat GFAP gene and identification of a novel alternative transcript. J Neurosci Res 56: 219-228.
9. Cullen DK, Simon CM, LaPlaca MC. 2007. Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures. Brain Res 1158: 103-115.
10. Dou C, Zhang J. 2011. Effects of lead on neurogenesis during zebrafish embryonic brain development. J Hazard Mater 194: 277-282.
11. Eng LF. 1985. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8: 203-214.
12. Eng LF, Ghirnikar RS, Lee YL. 2000. Glial fibrillary acidic protein: GFAPthirty-one years (1969-2000). Neurochem Res 25: 1439-1451.
13. Eng LF, Vanderhaeghen JJ, Bignami A, Gerstl B. 1971. An acidic protein isolated from fibrous astrocytes. Brain Res 28: 351-354.
14. Feinstein DL, Weinmaster GA, Milner RJ. 1992. Isolation of cDNA clones encoding rat glial fibrillary acidic protein: expression in astrocytes and in Schwann cells. J Neurosci Res 32: 1-14.
15. Fern R, Black JA, Ransom BR, Waxman SG. 1996. Cd(2+)-induced injury in CNS white matter. J Neurophysiol 76: 3264-3273.
16. Fowler BA, Whittaker MH, Lipsky M, Wang G, Chen XQ. 2004. Oxidative stress induced by lead, cadmium and arsenic mixtures: 30-day, 90-day, and 180-day drinking water studies in rats: an overview. Biometals 17: 567-568.
17. Galea E, Dupouey P, Feinstein DL. 1995. Glial fibrillary acidic protein mRNA isotypes: expression in vitro and in vivo. J Neurosci Res 41: 452-461.
18. Gomes FC, Paulin D, Moura Neto V. 1999. Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res 32: 619-631.
19. Holson RR, Freshwater L, Maurissen JP, Moser VC, Phang W. 2008. Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol 30: 326-348.
20. Jadhav SH, Sarkar SN, Kataria M, Tripathi HC. 2007. Subchronic exposure to a mixture of groundwater-contaminating metals through drinking water induces oxidative stress in male rats. Environ Toxicol Pharmacol 23: 205-211.
21. Kasten-Jolly J, Heo Y, Lawrence DA. 2011. Central nervous system cytokine gene expression: modulation by lead. J Biochem Mol Toxicol 25: 41-54.
22. Lepekhin EA, Eliasson C, Berthold CH, Berezin V, Bock E, Pekny M. 2001. Intermediate filaments regulate astrocyte motility. J Neurochem 79: 617-625.
23. Maurya SK, Rai A, Rai NK, Deshpande S, Jain R, Mudiam MK, Prabhakar YS, Bandyopadhyay S. 2012. Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling. Toxicol Sci 125: 473-487.
24. McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. 1996. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc Natl Acad Sci USA 93: 6361-6366.
25. Middeldorp J, Boer K, Sluijs JA, De Filippis L, Encha-Razavi F, Vescovi AL, Swaab DF, Aronica E, Hol EM. 2010. GFAPdelta in radial glia and subventricular zone progenitors in the developing human cortex. Development 137: 313-321.
26. Middeldorp J, Hol EM. 2011. GFAP in health and disease. Prog Neurobiol 93: 421-443.
27. Middeldorp J, Kamphuis W, Sluijs JA, Achoui D, Leenaars CH, Feenstra MG, van Tijn P, Fischer DF, Berkers C, Ovaa H, Quinlan RA, Hol EM. 2009. Intermediate filament transcription in astrocytes is repressed by proteasome inhibition. FASEB J 23: 2710-2726.
28. Miyagawa K, Narita M, Miyatake M, Kato K, Yamanaka K, Suzuki T. 2007. Behavioral analysis of chronic exposure to diphenylarsinic and associated influence on central nervous systems. Nihon Shinkei Seishin Yakurigaku Zasshi 27: 181-189.
29. Newmeyer DD, Ferguson-Miller S. 2003. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112: 481-490.
30. Nielsen AL, Holm IE, Johansen M, Bonven B, Jgensen P, Jgensen AL. 2002. A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins. J Biol Chem 277: 29983-29991.
31. Perng MD, Wen SF, Gibbon T, Middeldorp J, Sluijs J, Hol EM, Quinlan RA. 2008. Glial fibrillary acidic protein filaments can tolerate the incorporation of assembly-compromised GFAP-delta, but with consequences for filament organization and alphaB-crystallin association. Mol Biol Cell 19: 4521-4533.
32. Rai A, Maurya SK, Khare P, Srivastava A, Bandyopadhyay S. 2010. Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions. Toxicol Sci 118: 586-601.
33. Roelofs RF, Fischer DF, Houtman SH, Sluijs JA, Van Haren W, Van Leeuwen FW, Hol EM. 2005. Adult human subventricular, subgranular, and subpial zones contain astrocytes with a specialized intermediate filament cytoskeleton. Glia 52: 289-300.
34. Rojas-Castada JC, Vigueras-Villaser RM, Rojas P, Chez-Salda M, Gutirez-Pez O, Montes S, Rs C. 2011. Alterations induced by chronic lead exposure on the cells of circadian pacemaker of developing rats. Int J Exp Pathol 92: 243-250.
35. Sarchielli E, Pacini S, Morucci G, Punzi T, Marini M, Vannelli GB, Gulisano M. 2012. Cadmium induces alterations in the human spinal cord morphogenesis. Biometals 25: 63-74.
36. Shibuki K, Gomi H, Chen L, Bao S, Kim JJ, Wakatsuki H, Fujisaki T, Fujimoto K, Katoh A, Ikeda T, Chen C, Thompson RF, Itohara S. 1996. Deficient cerebellar long-term depression, impaired eyeblink conditioning, and normal motor coordination in GFAP mutant mice. Neuron 16: 587-599.
37. Stark M, Wolff JE, Korbmacher A. 1992. Modulation of glial cell differentiation by exposure to lead and cadmium. Neurotoxicol Teratol 14: 247-252.
38. Stoltenburg-Didinger G, Pder I, Peters B, Marcinkowski M, Herbst H, Winneke G, Wiegand H. 1996. Glial fibrillary acidic protein and RNA expression in adult rat hippocampus following low-level lead exposure during development. Histochem Cell Biol 105: 431-442.
39. Struzyka L, Bubko I, Walski M, Rafalowska U. 2001. Astroglial reaction during the early phase of acute lead toxicity in the adult rat brain. Toxicology 165: 121-131.
40. Struzynska L, Dabrowska-Bouta B, Koza K, Sulkowski G. 2007. Inflammation-like glial response in lead-exposed immature rat brain. Toxicol Sci 95: 156-162.
41. van den Berge SA, Middeldorp J, Zhang CE, Curtis MA, Leonard BW, Mastroeni D, Voorn P, van de Berg WD, Huitinga I, Hol EM. 2010. Longterm quiescent cells in the aged human subventricular neurogenic system specifically express GFAP-delta. Aging Cell 9: 313-326.
42. Wenzel J, Lammert G, Meyer U, Krug M. 1991. The influence of longterm potentiation on the spatial relationship between astrocyte processes and potentiated synapses in the dentate gyrus neuropil of rat brain. Brain Res 560: 122-131.
43. Yang CS, Tzou BC, Liu YP, Tsai MJ, Shyue SK, Tzeng SF. 2008. Inhibition of cadmium-induced oxidative injury in rat primary astrocytes by the addition of antioxidants and the reduction of intracellular calcium. J Cell Biochem 103: 825-834.
44. Zhao F, Liao Y, Jin Y, Li G, Lv X, Sun G. 2012. Effects of arsenite on glutamate metabolism in primary cultured astrocytes. Toxicol In Vitro 26: 24-31.